126 related articles for article (PubMed ID: 33906856)
1. Response to: 'Correspondence on 'EULAR December 2020 View points on SARS-CoV-2 vaccination in patients with RMDs'' by Bugatti
Bijlsma JWJ;
Ann Rheum Dis; 2021 Oct; 80(10):e157. PubMed ID: 33906856
[No Abstract] [Full Text] [Related]
2. Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs'.
Bugatti S; Balduzzi S; De Stefano L; Manzo A; Xoxi B; Bogliolo L; Monti S; Delvino P; Montecucco C
Ann Rheum Dis; 2021 Oct; 80(10):e156. PubMed ID: 33906858
[No Abstract] [Full Text] [Related]
3. EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs.
Bijlsma JW
Ann Rheum Dis; 2021 Apr; 80(4):411-412. PubMed ID: 33563595
[No Abstract] [Full Text] [Related]
4. EULAR 2021 updated viewpoints on SARS-CoV-2 vaccination in patients with RMDs: a guidance to answer patients' questions.
Bijlsma JW;
Ann Rheum Dis; 2022 Jun; 81(6):786-788. PubMed ID: 35121591
[No Abstract] [Full Text] [Related]
5. EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update.
Landewé RBM; Kroon FPB; Alunno A; Najm A; Bijlsma JW; Burmester GR; Caporali R; Combe B; Conway R; Curtis JR; Elkayam O; Gossec L; Heijstek MW; Haupt L; Iagnocco A; Isaacs JD; Juhász IÁ; Makri S; Mariette X; McInnes IB; Mehta P; Mueller-Ladner U; Schulze-Koops H; Smolen JS; Wiek D; Winthrop KL; Navarro-Compán V; Machado PM
Ann Rheum Dis; 2022 Dec; 81(12):1628-1639. PubMed ID: 35197264
[TBL] [Abstract][Full Text] [Related]
6. Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli
Chung SH; Wener M; Bays AM; Rahbar H; Morishima C; Bryan AB; Fink SL; Cohen S; Mani NS; Chaudhary A; Gardner GC
Ann Rheum Dis; 2021 Oct; 80(10):e165. PubMed ID: 34340981
[No Abstract] [Full Text] [Related]
7. Response to: 'Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'' by Westhoff
Bonelli M; Aletaha D
Ann Rheum Dis; 2021 Oct; 80(10):e163. PubMed ID: 34272251
[No Abstract] [Full Text] [Related]
8. Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response"by Bonelli
Benucci M; Damiani A; Infantino M; Manfredi M; Grossi V; Lari B; Li Gobbi F; Sarzi Puttini P
Ann Rheum Dis; 2021 Oct; 80(10):e166. PubMed ID: 34340979
[No Abstract] [Full Text] [Related]
9. Response to: Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli
Bonelli M; Aletaha D
Ann Rheum Dis; 2021 Oct; 80(10):e167. PubMed ID: 34340982
[No Abstract] [Full Text] [Related]
10. Response to: 'Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'' by Smerilli
Priori R; Pellegrino G; Colafrancesco S; Alessandri C; Ceccarelli F; Di Franco M; Riccieri V; Scrivo R; Sili Scavalli A; Spinelli FR; Conti F
Ann Rheum Dis; 2021 Oct; 80(10):e169. PubMed ID: 33962963
[No Abstract] [Full Text] [Related]
11. Correspondence on "Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry" by Machado
Bourguiba R; Delplanque M; Savey L; Hentgen V; Grateau G; Georgin-Lavialle S;
Ann Rheum Dis; 2023 Dec; 82(12):e228. PubMed ID: 35817471
[No Abstract] [Full Text] [Related]
12. Professionally responsible COVID-19 vaccination counseling-response to Chervenak et al.
Habiba M
Am J Obstet Gynecol; 2021 Sep; 225(3):355. PubMed ID: 34116034
[No Abstract] [Full Text] [Related]
13. Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli
Connolly CM; Koenig D; Ravi SN; Azar A; Kant S; Dalal M; Duchen J; Seo P; Antiochos B; Paik JJ; Geetha D
Ann Rheum Dis; 2021 Oct; 80(10):e164. PubMed ID: 34340978
[No Abstract] [Full Text] [Related]
14. Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha
Dejaco C; Bijlsma JW; Buttgereit F
Ann Rheum Dis; 2021 Oct; 80(10):e171. PubMed ID: 33509796
[No Abstract] [Full Text] [Related]
15. Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'.
Smerilli G; Cipolletta E; Moscioni E; Francioso F; Risa AM; Maccarrone V; Zompa D; Di Matteo A; Di Carlo M; De Angelis R; Salaffi F; Filippucci E; Grassi W
Ann Rheum Dis; 2021 Oct; 80(10):e168. PubMed ID: 33962960
[No Abstract] [Full Text] [Related]
16. [Current state of vaccination against SARS-CoV-2].
Iking-Konert C; Specker C; Krüger K; Schulze-Koops H; Aries P
Z Rheumatol; 2021 Mar; 80(2):158-164. PubMed ID: 33528655
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
Schulze-Koops H; Specker C; Skapenko A
RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439
[TBL] [Abstract][Full Text] [Related]
18. B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19.
Zollner A; Watschinger C; Rössler A; Farcet MR; Penner A; Böhm V; Kiechl SJ; Stampfel G; Hintenberger R; Tilg H; Koch R; Antlanger M; Kreil TR; Kimpel J; Moschen AR
EBioMedicine; 2021 Aug; 70():103539. PubMed ID: 34391087
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
Front Immunol; 2021; 12():690698. PubMed ID: 34276681
[TBL] [Abstract][Full Text] [Related]
20. Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021.
Teran RA; Walblay KA; Shane EL; Xydis S; Gretsch S; Gagner A; Samala U; Choi H; Zelinski C; Black SR
MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):632-638. PubMed ID: 33914721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
